Risk Cancer Research Results

Risk, Risk: Click to Expand ⟱
Source:
Type:
Risk: by definition reduces risk of disease or cancer.
Down Target direction of risk indicates lower cancer risk.
ChemoPreventive also mean lower cancer risk. But for Chemopreventive an up arrow indicates more preventive.
Cancer Risk Impact Score (CRIS)
CRIS scale:
–5 = very strong risk reduction
–4 = strong risk reduction
–3 = moderate risk reduction
–2 = modest risk reduction
–1 = weak / context-dependent
0 = neutral

CRIS Exposure / Compound Evidence Cancers Notes
-5 Exercise (overall) VStrong Hum BC, CRC, Endo, PCa, Liv
-5 Aerobic + resistance VStrong Hum Broad inc + mort
-4 Aerobic exercise (mod–vig) VStrong Hum BC, CRC, Endo
-4 Resistance training (alone) Strong Hum BC, CRC
-3 High-intensity interval training Mod–Strong Hum BC, CRC
-2 NEAT / low-intensity activity Moderate Hum CRC
-5 Cruciferous vegetable pattern Strong Hum Lung, CRC, BC, PCa
-5 Sunlight exposure (physiologic) Strong Hum CRC, BC, PCa
-4 Fasting (metabolic pattern) Strong Mech + Hum BC, CRC, PCa
-4 Curcumin Hum + Pre GI, BC, PCa
-4 Sulforaphane Hum + Pre Lung, CRC, BC
-4 PEITC Hum + Pre Lung, CRC, PCa
-4 EGCG (tea matrix) Strong Hum GI, PCa, BC
-4 Lycopene Strong Hum PCa
-4 Apigenin Pre + Diet Hum BC, PCa, CRC
-4 Luteolin Pre + Diet Hum Lung, CRC, BC
-4 Kaempferol Diet Hum Ov, Panc, Lung
-4 Fisetin Pre + Early Hum CRC, PCa, Mel
-4 Ellagic acid → Urolithin A Hum (microbiome) CRC, PCa, BC
-3 Omega-3 (EPA/DHA) Strong Hum CRC, BC
-3 Vitamin D3 (supp) Obs + RCT CRC, BC
-3 Garlic (allicin) Mod Hum GI
-3 Mushroom beta-glucans Hum adjunct GI, BC
-3 Melatonin Hum + Mech BC, PCa
-3 Coffee (whole) Strong Hum Liv, Endo
-2 Quercetin Limited Hum Lung, CRC
-2 Resveratrol Limited Hum CRC, BC
-2 I3C / DIM Mod Hum BC, Cerv
-2 Thymoquinone Early Hum BC, CRC
-2 Beta-carotene (food) Hum Lung
-1 Vitamin K2 (MK-4/7) Limited Hum Liv, PCa
-1 Boron Obs PCa, Lung
0 Vitamin C (oral) Strong Hum
0 Genistein (soy) Strong Hum BC, PCa
0 Selenium (diet) Mixed Hum PCa
0 Capsaicin Mixed Gastric
+2 Vitamin E (alpha only) Strong RCT PCa
+2 Green tea extract (high-dose) Case reports Liv
+4 Beta-carotene (supplement) Strong RCT Lung (smokers)
+5 Alcohol (ethanol) Strong Hum BC, Liv, Eso
Evidence Hum human data VStrong very strong Strong strong Mod moderate Obs observational Pre preclinical RCT randomized controlled trial Mech mechanistic Adjunct adjunct clinical use


IBD, Inflammatory Bowel Disease: Click to Expand ⟱
Inflammatory Bowel Disease

The main pathways involved in IBD include intestinal barrier dysfunction, mucus barrier impairment, dysbiosis-driven innate immune activation, and persistent cytokine-mediated inflammation. Key barrier components such as ZO-1, occludin, claudins, and MUC2 are commonly disrupted, increasing epithelial permeability and microbial translocation. This promotes activation of inflammatory hubs including TNF-α, NF-κB, IL-1β, IL-6/STAT3, and IL-23/Th17, while JAK/STAT signaling integrates multiple cytokine inputs that sustain chronic mucosal injury. Together, these pathways drive epithelial damage, immune dysregulation, and failure of mucosal healing in ulcerative colitis and Crohn’s disease

Rank Pathway / Axis Representative Targets / Markers Typical Direction in IBD Main Relevance
1 Intestinal Barrier Integrity / Tight Junctions ZO-1 (TJP1), Occludin (OCLN), Claudins (especially CLDN2, CLDN1) ZO-1 ↓, OCLN ↓, barrier loosened; CLDN2 often ↑ Core barrier failure increases intestinal permeability, microbial entry, and chronic inflammation
2 Mucus Barrier / Goblet Cell Axis MUC2, goblet cells, antimicrobial peptides MUC2 and goblet protection often impaired Weak mucus defense exposes the epithelium to luminal bacteria and antigens
3 TNF-α Inflammatory Axis TNF-α, TNFR1, TNFR2 Major inflammatory driver and validated therapeutic target in IBD
4 NF-κB Signaling NF-κB, IKK, IκB, COX-2, iNOS Central transcriptional hub for cytokines, chemokines, and inflammatory amplification
5 IL-23 / Th17 Axis IL-23, IL-23R, IL-17A, IL-22, RORγt ↑ / dysregulated Important bridge between innate and adaptive immune inflammation
6 JAK / STAT Signaling JAK1, JAK2, TYK2, STAT3 ↑ / activated Integrates multiple cytokine signals that sustain mucosal inflammation
7 IL-6 / STAT3 Axis IL-6, IL-6R, gp130, STAT3 Supports inflammatory persistence, immune-cell survival, and epithelial injury signaling
8 IL-1β / Inflammasome Axis IL-1β, NLRP3, ASC, caspase-1 Promotes innate inflammation, cytokine escalation, and epithelial damage
9 Microbiota / Dysbiosis / PRR Signaling Dysbiosis, TLRs, MyD88, LPS-related signaling Dysregulated / activated Links altered microbiota to barrier loss and immune activation
10 Oxidative Stress / Redox Imbalance ROS, lipid peroxidation, MPO, antioxidant defenses ↑ oxidative stress Contributes to epithelial injury, inflammatory signaling, and impaired healing
11 Leukocyte Trafficking / Adhesion Integrins, MAdCAM-1, ICAM-1, VCAM-1, chemokines Drives immune-cell recruitment into inflamed intestinal tissue
12 Epithelial Apoptosis / Restitution / Mucosal Healing Caspases, repair pathways, epithelial proliferation and restitution markers Injury ↑, healing impaired Determines whether mucosal damage resolves or progresses to chronic disease
Rank Natural Product Best Fit in IBD Evidence Level Main Rationale Notes
1 Curcumin Mainly Ulcerative Colitis (UC) Best human evidence Strongest overall adjunctive clinical support among common natural products for active UC Anti-inflammatory; NF-κB / cytokines / oxidative stress; mucosal support
2 Indigo naturalis (Qing Dai) Mainly UC Strong efficacy, safety-limited Good human efficacy signals, but safety concerns lower practical rank Anti-colitic; immune/inflammatory modulation; use caution flag for safety
3 Boswellia serrata UC / colitis Older smaller human trials Suggestive remission data and anti-inflammatory relevance, but evidence base is limited 5-LOX / leukotrienes / inflammation / mucosal protection
4 Aloe vera gel Mild-to-moderate UC Small human trial signal Some human improvement signal, though not as strong as curcumin or indigo naturalis Mucosal soothing / anti-inflammatory / healing support
5 Andrographis paniculata / andrographolide Mostly UC Mixed human, stronger preclinical Mechanistically promising, but human benefit is less consistent NF-κB / cytokines / barrier and anti-inflammatory support
6 Carvacrol Experimental colitis / dysbiosis / barrier dysfunction Preclinical Promising anti-colitis terpene with anti-inflammatory, antioxidant, and microbiota-related effects Dysbiosis / intestinal barrier integrity / NF-κB / oxidative stress
7 Thymol Experimental colitis / barrier dysfunction Preclinical Promising anti-colitis terpene with cytokine suppression and NF-κB-related effects Dysbiosis / intestinal barrier integrity / NF-κB / COX-2 / oxidative stress
8 Carvacrol + Thymol Experimental colitis, dysbiosis, bile-acid modulation Preclinical, mechanistically strong Combination may be especially relevant due to microbiota and bile-acid pathway effects in DSS colitis Bifidobacterium / secondary bile acids / barrier support / anti-colitic signaling
9 Peppermint oil Supportive / experimental colitis / GI symptom relief Mainly preclinical for IBD; stronger IBS evidence Menthol-rich oil with anti-inflammatory, antispasmodic, and possible barrier-supportive effects, but limited direct human IBD evidence Menthol / TRP modulation / cytokines / oxidative stress / GI symptom support


Scientific Papers found: Click to Expand⟱
5932- CAR,    Carvacrol attenuates mucosal barrier impairment and tumorigenesis by regulating gut microbiome
- in-vivo, IBD, NA - in-vivo, Park, NA
*GutMicro↑, Risk↓, *Inflam↓, *antiOx↓, *ZO-1↑, *iNOS↓, *IL6↓, *NO↓, *PGE2↓, *memory↑, *TLR4↓, *NF-kB↓, *IBI↑, *CLDN3↑, *CLDN1↑, *MUC1↑, *OCLN↑, *iNOS↑, *COX2↓, *IFN-γ↓, IL1β↓, ADAM10?,
6084- CHOC,    Cocoa Polyphenols and Their Potential Benefits for Human Health
- Review, Nor, NA - Review, Stroke, NA - Review, IBD, NA
*lipid-P↓, *ROS↓, *Inflam↓, *BP↓, *cardioP↑, *chemoPv↑, *BioAv⇅, *antiOx↑, *Risk↓, *5LO↓, *AntiAg↑, *Imm↑, *NF-kB↓, *other↓, CYP1A1↓, COX2↓, *Obesity↓, *cognitive↑,
4609- SeNPs,    Physiological Benefits of Novel Selenium Delivery via Nanoparticles
- Review, Var, NA - Review, IBD, NA - Review, Diabetic, NA
*selenoP↑, Risk↓, AntiCan↑, ROS↑, *Dose↝, *toxicity↓, *BioAv↑, *GutMicro↑, *other↓,
4498- SSE,    Selenium in Human Health and Gut Microflora: Bioavailability of Selenocompounds and Relationship With Diseases
- Review, Var, NA - Review, AD, NA - Review, IBD, NA
*Imm↑, *GutMicro↑, *BioAv↑, *Risk↓, *Dose↝, Risk↓, *CRP↓, *GPx↓, *Inflam↓, *selenoP↑, *Dose↝, *ROS↓, *MDA↓, *SOD↑, *GPx↑, *IL1↓, *MCP1↓, *IL6↓, *TNF-α↓, Risk↓, *neuroP↑, *memory↑,
4497- SSE,    Selenium and inflammatory bowel disease
- Review, Var, NA - Review, IBD, NA
*GutMicro↑, *selenoP↑, *Inflam↓, Risk↓, *NF-kB↓, *ROS↓,
4494- SSE,    Advances in the study of selenium and human intestinal bacteria
- Review, IBD, NA - Review, Var, NA
*Risk↓, OS↑, *CRP↓, *GPx↑, *Inflam↓, *ROS↓, *GutMicro↑, *selenoP↑, *other↓,

Showing Research Papers: 1 to 6 of 6

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

CYP1A1↓, 1,   ROS↑, 1,  

Immune & Inflammatory Signaling

COX2↓, 1,   IL1β↓, 1,  

Synaptic & Neurotransmission

ADAM10?, 1,  

Functional Outcomes

AntiCan↑, 1,   OS↑, 1,   Risk↓, 5,  
Total Targets: 8

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↓, 1,   antiOx↑, 1,   GPx↓, 1,   GPx↑, 2,   lipid-P↓, 1,   MDA↓, 1,   ROS↓, 4,   selenoP↑, 4,   SOD↑, 1,  

Cell Death

iNOS↓, 1,   iNOS↑, 1,  

Transcription & Epigenetics

other↓, 3,  

Migration

5LO↓, 1,   AntiAg↑, 1,   CLDN1↑, 1,   MUC1↑, 1,   ZO-1↑, 1,  

Angiogenesis & Vasculature

NO↓, 1,  

Barriers & Transport

CLDN3↑, 1,   IBI↑, 1,   OCLN↑, 1,  

Immune & Inflammatory Signaling

COX2↓, 1,   CRP↓, 2,   IFN-γ↓, 1,   IL1↓, 1,   IL6↓, 2,   Imm↑, 2,   Inflam↓, 5,   MCP1↓, 1,   NF-kB↓, 3,   PGE2↓, 1,   TLR4↓, 1,   TNF-α↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 2,   BioAv⇅, 1,   Dose↝, 3,  

Clinical Biomarkers

BP↓, 1,   CRP↓, 2,   GutMicro↑, 5,   IL6↓, 2,  

Functional Outcomes

cardioP↑, 1,   chemoPv↑, 1,   cognitive↑, 1,   memory↑, 2,   neuroP↑, 1,   Obesity↓, 1,   Risk↓, 3,   toxicity↓, 1,  
Total Targets: 48

Scientific Paper Hit Count for: Risk, Risk
3 Selenite (Sodium)
1 Carvacrol
1 Chocolate
1 Selenium NanoParticles
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:58  Cells:%  prod#:%  Target#:785  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page